Latest news and press releases about Progyny, Inc. (PGNY): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists.
Price
| Price | $25.86 |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 27.42 |
| Price / Book | 4.28 |
| EV / EBITDA | 15.02 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 15.98% |
| Return on Invested Capital | 15.32% |
| Return on Assets | 10.98% |
| Gross Margin | 24.57% |
| Operating Margin | 8.55% |
| Net Margin | 6.00% |
Related companies: ALVO · GDRX · OMCL · OMDA · PHR · SDGR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of PGNY: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks